NCT01333163已完成不适用
GLP-1: Acute Effects on Kidney Function in Healthy Men
Jeppe Skov1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2011年5月1日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 12
- 试验地点
- 1
- 主要终点
- Glomerular Filtration Rate
研究概览
简要总结
The purpose of this study is to investigate how Glucagon-Like Peptide 1 (GLP-1) affects kidney function in healthy young men. The hypothesis is that GLP-1 induces a positive effect on kidney hemodynamics.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 30 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Healthy young men
排除标准
- •Any chronic diseases
研究组 & 干预措施
GLP-1
Active Comparator
干预措施: Human GLP-1 (7-36) amide (Biological)
Placebo
Placebo Comparator
干预措施: Isotone NaCl (Biological)
结局指标
主要结局
Glomerular Filtration Rate
时间窗: Every 20 minutes for 6 hours
次要结局
未报告次要终点
研究者
Jeppe Skov
MD
University of Aarhus
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Acute Effects of GLP-1 on Renal HemodynamicsThe GLP-1-mediated Gut-kidney AxisNCT04337268Rigshospitalet, Denmark10
已完成
2 期
Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney DiseaseChronic Kidney DiseasesNCT05254418Vanderbilt University Medical Center7
尚未招募
不适用
Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and NephropathyKidney Disease, ChronicDiabetes Mellitus, Type 2NCT06555146Bispebjerg Hospital15
进行中（未招募）
1 期
A study to evaluate the effect of a licensed drug to lower blood glucose, liraglutide, on inflammation in patients with diabetic kidney disease.Diabetic Kidney DiseaseMedDRA version: 18.0Level: LLTClassification code 10012687Term: Diabetic renal diseaseSystem Organ Class: 100000004857EUCTR2012-005482-12-IEniversity College Dublin
已完成
1 期
The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart FailureHeart FailureNCT02129179Papworth Hospital NHS Foundation Trust10